纽泰克斯医疗 NUTX
$180.56 −$13.08 (-6.75%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $182.66 +1.16%
开盘$175.50
昨收$193.64
当日区间$170.00 – $190.00
成交量168.3K
市值$1.24B
市盈率（TTM）7.8
股息率–
NUTX 相关新闻
匹配 Nutex Health 或代码 NUTX 的头条新闻，按最新排序。
- B. Riley Securities Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $325
- Lake Street Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $310
- Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $200 正面
- Lake Street Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $310 正面
- B. Riley Securities Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $290
- Lake Street Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $235
- Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $175
- Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $175 正面
- Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Clinigence Holdings (NUTX)
- Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Cuts Target Price to $150 负面
- Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $300
- Ladenburg Thalmann Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $336
- Benchmark Co. Reaffirms Their Buy Rating on Clinigence Holdings (NUTX)
- Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Cuts Target Price to $205 负面
- TR | OpenAI - 4o Downgrades Nutex Health(NUTX.US) to Hold Rating, Cuts Target Price to $100 负面
暂无评论——快来第一个聊聊 NUTX。